Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

May UNC Health System Pharmacy Resident CE Series (Online)


Due to concerns about the novel coronavirus, and consistent with ongoing efforts to reduce spread of the virus, attendance for these CE sessions will be WEBINAR ONLY.  Please see instructions below for registration.
 
PLEASE FOLLOW THE STEP-BY-STEP INSTRUCTIONS BELOW – DO NOT SKIP STEPS!
 
STEP 1:  SIGN INTO YOUR ACCOUNT AND REGISTER FOR EACH SESSION YOU WOULD LIKE TO ATTEND
** If you do not register for the CE at this link, you will not be able to access the evaluations to earn credit
** EVERYONE must register BEFORE the session date. NO NEW REGISTRATIONS WILL BE ADDED AFTER THE PROGRAM DATE
** You will receive an email confirming your registration at the email address provided – if you do not receive a confirmation email, try to register again
**New sessions may be added throughout the month, so do not assume you are automatically registered for all sessions.
 
STEP 2:  AFTER SUCCESSFULLY REGISTERING ON THIS SITE - AT THE TIME OF THE PROGRAM, EXPAND THE MODULE AT THE BOTTOM OF THIS PAGE AND CLICK THE WEBEX LINK.
The Link will not be emailed to you. It can only be found on this page.
** submit your contact information
 
STEP 3:  Collect the presenter code for each of the CEs that you attend
** EVERYONE will need the presenter codes to access evaluations and earn CE credit
 
STEP 4:  You will receive an automated email to log in and complete evaluations
** Evaluations must be completed within 60 days of the CE session
** You will need the presenter codes to access each evaluation
** Evaluations MUST be completed within 60 days of the program date to earn CE credit!

Date: May 1, 2021 01:00 AM - May 31, 2021 06:00 PM

CE Hours

5.50

CE Units

0.550

Registration closes on May 31, 2021 01:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
 
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.

 

If paying by check please mail to the address below:

UNC Eshelman School of Pharmacy
Attn: Continuing Education
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
 
 
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**

Co-Sponsor(s)

UNC Health System

Support/Credits

 
 
 
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
 
 
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
 
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series.
  1. UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
  2. Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded

 

 

 

   

This presentation will discuss current treatment options for myasthenia gravis, with a focus on newer immunotherapies. Pharmacists will be able to use this information to enhance their patient care when encountering a patient with myasthenia gravis.
 

Objectives

  • Define the pathophysiology and subtypes of myasthenia gravis (MG)
  • Describe the general treatment options for MG
  • Analyze the role of immunotherapies in the treatment of MG
  • Outline the role of a pharmacist in MG treatment

Speaker(s)/Author(s)

Domenica Ricciuti, PharmD
PGY1 Ambulatory Care Pharmacy Resident , UNC Health

Activity Number

0046-9999-21-124-L01-P
Date: 05/06/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
   

 

   

In this session, attendees will gain an overall understanding of the history, framework, and use of balanced scorecards within pharmacy practice.
 
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content

Objectives

  • Outline what a balanced scorecard is and how it can be utilized to drive performance.
  • Review examples of balanced scorecards within pharmacy practice.
  • Describe how the visualization of data can be used to optimize pharmacy performance.

Speaker(s)/Author(s)

Charles M. Summerlin, PharmD
PGY1 Health-System Pharmacy Administration and Leadership Resident

Activity Number

0046-9999-21-123-L04-P
Date: 05/13/21
Time: 06:00 PM - 06:30 PM

CE Hours

0.50

Fee

$5.00

Location

Online
   

   

This session will provide in-depth knowledge and present up to date literature for practicing pharmacists on managing a specialized and high risk patient population of abdominal solid organ transplant recipients that have COVID-19 infections. The aim of this presentation will be to instill confidence and provide knowledge on identifying particularly high risk patients for severe COVID-19 infection, literature on managing immunosuppressive medication regimens, best practices for treatment of COVID-19 infections in these patients, and literature on guiding COVID-19 vaccination recommendations.
 
 
 
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content

Objectives

  • Describe risk factors and common demographics for COVID-19 infection in abdominal transplant recipients
  • Demonstrate an ability to appropriately modify immunosuppression regimens in abdominal transplant recipients with COVID-19
  • Discuss common treatment guidance for abdominal transplant recipients with COVID-19, especially pertaining to dexamethasone and remdesivir therapies
  • Review current literature to inform recommendations for COVID-19 vaccination of abdominal transplant recipients

Speaker(s)/Author(s)

Alyson Prom, PharmD
PGY1 Pharmacy Resident

Activity Number

0046-9999-21-129-L01-P
Date: 05/13/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Fee

$10.00
   

 

   

This session will provide in depth knowledge to practicing pharmacists on the most up to date literature surrounding pathophysiology, initial assessment and treatment approaches to venomous snakebites. The intended aim of this presentation is to equip pharmacists with the knowledge needed to most appropriately manage and recommend therapy to these patients by evaluating in detail the existing evidence surrounding the various pharmacologic and nonpharmacologic treatment approaches to managing patients with venomous snakebites. This review of literature will allow pharmacists to provide individualized care for each patient, thus improving outcomes associated with mild to severe venomous snakebites.
 

Objectives

  • Understand the epidemiology, pathophysiology and clinical triads of snake envenomation.
  • Identify appropriate supportive measures and indications for antivenom administration.
  • Outline the published literature regarding antivenom therapy in the United States used to treat venomous snakebites.
  • Describe a comprehensive treatment plan for a patient presenting with a venomous snakebite.

Speaker(s)/Author(s)

Meghin Moynihan, PharmD
PGY1 Pharmacy Resident

Activity Number

0046-9999-21-165-L01-P
Date: 05/20/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Fee

$10.00
   

 

   

Program held from 1p-2p, then repeated from 2p-3p
 
Session 1:
Meeting Number: 160 471 9322
Password: u3EmMw7HsX7
 
Session 2:
Meeting Number: 160 865 5780
Password: ChubiHKa673

Objectives

  • Review multiple myeloma and standard treatment for relapsed/refractory disease
  • Outline recent literature analyzing the efficacy and safety of novel agents in relapsed/refractory disease
  • Discuss ongoing trials and future implications for treatment of relapsed/refractory disease

Speaker(s)/Author(s)

Rebecca Farley, PharmD
PGY1 Pharmacy Resident

Activity Number

0046-9999-21-168-L01-P
Date: 05/25/21
Time: 01:00 PM - 03:00 PM

CE Hours

1.00

Fee

$10.00

Location

Online
   

 

   

This session will provide education about the use of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction. This will include a review of the pharmacology, proposed mechanisms of cardiac benefit, analysis of available literature regarding the use of SGLT2i in both stable and acute heart failure, and a discussion about the potential barriers to SGLT2i initiation. This presentation will also include a discussion of the order of guideline-directed medical therapy (GDMT) that is used most commonly, including the proposal of a revised order of initiation with rationale. This will change clinical practice by giving pharmacists the evidence and tools needed to successfully initiate SGLT2 inhibitors, as well as a strategy to ensure all GDMT agents  are initiated within 4 weeks, thus drastically improving morbidity and mortality.
 

Objectives

  • Describe the proposed mechanism of action of SGLT2i
  • Outline the literature regarding the use of SGLT2i in HFrEF
  • Discuss potential barriers to SGLT2i initiation
  • Describe an alternative algorithm for GDMT initiation

Speaker(s)/Author(s)

Kaitlin Musick, PharmD
PGY1 Acute Care Pharmacy Resident

Activity Number

0046-9999-21-164-L01-P
Date: 05/27/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Fee

$10.00